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Peptides derived from processing of complex protein antigens interact with prod-
ucts of the MHC to form the ligand recognized by T cells (1, 2). Recent crystallo-
graphic data support competitive binding studies showing that peptides restricted
by the same MHC molecule bind to a limited number of sites on MHC (3-5). Self
peptides that are nonimmunogenic include motifs that are predictive ofMHC binding
and can compete for Ia binding with similar immunogenic peptides, thereby
modulating the response to the foreign peptide (6, 7). Therefore, selfpeptides may
influence the response to foreign antigens in several ways: by competing for antigen
presentation by binding to MHC sites; and through modifying the development
of the T cell repertoire by clonal selection in the thymus of T cells bearing receptors
reacting with self antigens as shown for I-E and Mls-reactive T cells (8, 9). The
data presented here suggest that insulin B chain may function as an immunoregula-
tory peptide in man by both pathways: homology with the constant region of the
TCR (3 chain results in a paucity of peripheral T cells recognizing insulin B chain;
and B chain competes effectively at the level ofthe APC for presentation ofimmuno-
genic A chain determinants.
Antigens.
￿
Crystalline bovine insulin and S-sulfated human insulin B chain were the generous
gift ofDr. Ron Chance (Lilly Research Laboratories, Indianapolis, IN). S-carboxymethylated
bovine insulin B chain was synthesized in the laboratory of Dr. Dietrich Brandenberg
(Deutsches Wollforschunginstitut, Aachen, FRG) and kindly provided by Dr. Alan Rosen-
thal (Merck Institute, Rahway, NJ).
Cells and Assay Conditions.
￿
Insulin-specific T cell clones 2/31, 2/37, and 3/50 were derived
from a DRI, w6 diabetic and maintained by intermittent stimulation with insulin, IL2, and
irradiated autologous mononuclear cells (MNC) as described (10). APC used were irradiated
autologous MNC or EBVtransformed B cells (EBV B cells). Proliferation assays were per-
formed as described (10) in triplicate in U-bottomed plates; each well contained 2 x 104 T cells
and 105 irradiated APC in 0.2 ml. Cultures were incubated for 72 h and received 1 tiCi
methyl-('H]thymidine during the final 18 h of incubation. Data are the mean cpm f SD of
triplicate wells. For antigen pulsing experiments, EBV B cells were incubated overnight with
insulin and/or inhibitor (25 pM each) at a final density of 1.5 x 106/ml in 24-well flat-bot-
tomed plates. Washed cells were fixed in paraformaldehyde for 1 min as previously detailed (11).
This work was supported by National Institutes of Health grant DK-32329. J. F. Hoy's present address
is Fairfield Infectious Diseases Hospital, Fairfield, Victoria, 3078, Australia. Address correspondence
to James W. Thomas, M.D., Department of Medicine, Baylor College of Medicine, One Baylor Plaza,
Houston, TX 77030.
J. Exp. MED. © The Rockefeller University Press - 0022-1007/89/06/2251/06 $2.00
￿
22512252
￿
MILLER ET AL .
￿
BRIEF DEFINITIVE REPORT
Results and Discussion
Insulin B Chain Competes with Immunogenic A Chain Determinants.
￿
Human T cell
clones specific for insulinwere derived from an insulin-treateddiabetic ; theseT cells
require processing of insulin and recognize determinants on the A chain of bovine
insulin in association with HLA-DRI (10, 11). In contrast to guinea pigT cells (12),
no human T cell clones were found that recognized insulin B chain. We therefore
examined the effects of insulin B chain on the response of three beef insulin-specific
T cell clones with differing fine specificities (11) . The response of clone 3/50 to in-
sulin was inhibited in a dose-dependent fashion by isolated B chain (Fig . 1 A) . Inhi-
bition was detected at 1 uM B chain, and the response was completely inhibited
by 30 uM B chain. Inhibition was found with either autologous MNC or EBV B
cells as APC. Both human and bovine insulin B chain, differingby one amino acid
(1130), were inhibitory, irrespective of the modification of the cysteines (S-carboxy-
methylated or S-sulfated) . Similar results were found for clones 2/31 and 2/37 (Fig.
1 B and data not shown) .
To ascertain if the B chain was acting on the TCR complex, we examined the
response of clone 2/37 (Fig . 1 B) . This clone has dual specificity for the A loop of
beef insulin in association with HLA-DR1 and is also alloreactive to a determinant
expressed on cells bearingHLA-DR3DQw2 molecules in the absence of insulin (10) .
As shown, B chain inhibited the insulin response of this clone while the alloreac-
tivity was not affected . These experiments excluded nonspecific toxicity ofB chain
and show that inhibition was probably not due to direct interaction with the TCR
complex . In additional experiments, T cells maintained in the presence ofB chain
were fully responsive to antigen excluding tolerization as a mechanism for inhibi-
tion (data not shown) .
To further examine the ability of B chain to compete withA chain determinants
for presentation toT cells, the following experiments were carried out. APC were
pulsed with insulin alone, insulin plus B chain, or B chain alone and allowed to
process antigen prior to fixation . T cell response to insulin-pulsed, fixed APC was
inhibited by the addition of B chain to the cultures (Fig . 2 A) . When APC were
FIGURE 1.
￿
Inhibition ofT cell
response to beef insulin by in-
sulin B chain . (A) Clone 3/50
was cultured with 5jM beefin-
sulin and APC (O, 0, autolo-
gous mononuclear cells ; " ,
EBVB cells) in the absence or
presence of the indicated con-
centrations of B chain (-, S-
sulfated human insulinBchain ;
- -, S-carboxymethylated bo-
vine insulinBchain) . (B) Clone
2/37 was cultured with autolo-
gous mononuclear cells(p) or
DRl EBV B cells (®) plus l0 aM beef insulin, or with DR3DQw2 EBV B cells (®) without insulin
in the absence or presence of 30 pM S-sulfated B chain . Controls : (A) clone 3/50 plus mononuclear
cells alone, 201 t 56; clone 3/50 plus EBV B cells alone, 1,702 t 109; EBVB cells alone, 989 t 104 .
(B) Clone 2/37 plus mononuclear cells, 386 t 198 ; 2/37 plus DR1 EBV B cells, 1,287 t 212 ; DRl
EBV B cells alone 1,300 ± 96 ; DR3DQw2 EBV B cells alone, 1,064 t 165 .FIGURE 2 .
￿
B chain competes
with insulin for antigen presen-
tation . (A) EBV B cells were
pulsed with beef insulin and
fixed with paraformaldehyde
before use as stimulators for
3/50 in the absence or presence
of the indicated concentration
of human insulin B chain . (B) _
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￿
_
￿
3/50 T cells were cultured with
irradiated EBVB cells that had
been pulsed with beef insulin alone (25 t.M) (p), simultaneously with beef insulin plus B chain (25
,uMeach) (®), pulsed separately with insulin (25 pM) andBchain (25kM) and mixed (®), orB chain
alone (25AM) 0), before fixation with paraformaldehyde . (C Same as B, except 2/37T cell responders .
Control responses (A, B) 3/50 plus nonpulsed EBV B cells, 1,072 f 109 ; EBV B cells alone, 1,100 ±
202 : (C 2/37 plus nonpulsed EBV B cells, 1,325 t 226 ; EBV B cells alone, 974 ± 276 .
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pulsed simultaneously with insulin andB chain priorto fixation, inhibition was also
observed (Fig. 2, B and C) . However, iftheAPC were pulsed separately with insulin
or B chain and then mixed, the T cell response was not inhibited (Fig . 2, B, C) .
Thus, the B chain competes with other insulin epitopes at the surface of APCs .
Sequence Homology ofInsulinB Chain and TCR,B Chain Constant Region .
￿
The amino
acid sequence of insulin B chain includes several motifs that are frequently predic-
tive ofT cell epitopes (13) including several appropriately spaced hydrophobic residues
that are recognized by other DRl-restricted humanT cells (14) . TheA chain of in-
sulin includes only one such motifproximal to theAloopwhichstimulates theclones
describedhere, but none of our clones recognizeB chain . Whenwe searched Gene-
bank for proteins with homology to insulin B chain, two clusters ofamino acid se-
quence identity with human and murine TCR /3 chain constant regions were found
(Fig. 3) . Therefore several B chain peptides were tested for inhibition of antiinsulin
responses (Table I) . These peptides include subunits spanning the entire B chain,
but none of them individually or in mixtures were inhibitory. Peptides spanning
residues 16-26 of theB chain and corresponding peptides of theTCRa chain have
thus far been insoluble in any diluent that is nontoxic to the cell cultures . We have
been unable to test directly thehypothesis that both homology clusters must be present
on the same peptide for inhibition .
These experiments demonstrate that a nonimmunogenic portion of the insulin
molecule inhibits the response to immunogenic epitopes of the same molecule . To-
gether with dataon DRl-restricted recognition by otherT cell clones (14), the most
direct conclusion is that insulin B chain competes with processed A chain epitopes
forMHC binding . This conclusion is supported by recent studies that show that
B chain binds murine class II MHC molecules from responder and nonresponder
haplotypes (15) . An alternative mechanism consistent with the data is binding of
B chain byMHC leadingto inhibition of the interaction betweenclass II molecules
m
FIGURE 3 .
￿
Sequence homology of insulin B chain (B16-
26) and the first exon ofTCR S chain constant regions
(140-150) .
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TABLE I
Intact B Chain Is Required to Inhibit T Cell Response to Insulin
Clone 3/50 was cultured with irradiated DR1 EBV B cells plus 10 tLM beef in-
sulin (Exp. 1) or mononuclear cells plus 5 1AM beef insulin (Exp. 2) in the ab-
sence (none) or presence of B chain [B (1-30)] or peptides (20 UM final
concentration). Results are A cpm for triplicate assays. Controls: Exp. 1, clone
plus DR1 EBV B cells alone 5,733 t 980; Exp. 2, clone plus mononuclear cells
alone 650 + 132.
and CD4. In either case, the effects of the 8 chain provide a mechanism by which
self peptides may modify the response to foreign antigens.
The homology with the constant region of the TCR R chain indicates that B
chain-related epitopes are also present in the thymus during development of the
T cell repertoire. This homology is found in both humanand murine Tcell receptor
(3 chains. Analysis of the specificity of murine T cell hybridomas has demonstrated
the dominance of A chain epitopes in the response to beef and pork insulin (16, 17).
Although some of these T cells recognize determinants that include the proximal
B chain disulfide linked to A chains (17), no murine clones responsive to isolated
B chains have been reported. Bchainresponsive Tcellsarefound in strain 13 guinea
pigs (12); these T cells recognize a determinant (B5-16) proximal to the sequences
homologous to the TCR. In man, polyclonal T cells were reported to react to iso-
lated B chains and somewhat to A(16-21)/B(10-25), but poorly or not at all to A(20-
21)/B(17-25) (18). Intrathymic homology may be one means of establishing T cell
tolerance to self molecules that are not present in the thymus and provide an addi-
tional mechanism by which self peptides modify responses to foreign antigens. If
the proposed use ofpeptides as immunotherapy of autoimmune disease is to be suc-
cessful, these experiments suggest that the most effective peptides should include
motifs that predict interaction with MHC and are present in the thymus during
T cell development.
Summary
The B chain of mammalian insulins contains appropriately spaced amino acids
that predict recognition by T cells. However, all T cell clones from an HLA-DR1,
Dw6 diabetic donor recognize epitopes associated with the A chain, and the B
chain was found to inhibit these responses. Effective intramolecular competition
at the level of the APC, not a direct effect on the T cell, is responsible for the in-
hibition. Insulin B chain contains two clusters of amino acid homology with the
B chain peptide Exp. 1 Exp. 2
None 11,341 5,671
B chain (1-30) 4,852 917
B (1-8) 11,579 NT
B (1-16) 11,572 6,703
B (1-23) 11,414 6,041
B (17-23) 10,114 NT
B (24-30) 11,145 NT
B (1-23) + B (24-30) NT 5,100
B (1-16) + B (24-30) NT 6,280
B (17-23) + B (24-30) NT 6,712MILLER ET AL.
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TCR (3 chain and B chain peptides lacking these clusters do not compete for antigen
presentation. A hole in the repertoire for T cells that recognize this portion of the
insulin molecule may arise in the thymus by deletion ofTcells that recognize similar
peptides.
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